Toronto - Delayed Quote CAD

DRI Healthcare Trust (DHT-UN.TO)

12.40

+0.05

+(0.40%)

At close: May 12 at 4:00:00 PM EDT

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced its financial results for the quarter ended March 31, 2025. The Trust's first quarter 2025 financial statements and Management's Discussion & Analysis ("MD&A") have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated.

CNW Group 3 hours ago

DHTRF
DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2025 financial results on Tuesday, May 13, 2025, at 8:00 a.m. ET. The Trust will report its financial results on Monday, May 12, 2025, after market close.

CNW Group 20 days ago

DHTRF
Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

DRI Healthcare Trust (TSX: DHT.UN/DHT.U) ("DRI" or "the Trust") today informs its unitholders of an adjustment to its previously announced quarterly cash distribution to unitholders of record as at March 31, 2025. This adjustment is required due to the occurrence of a Canadian statutory holiday on the originally scheduled payment date.

CNW Group 2 months ago

DHTRF
DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the fourth quarter and year ended December 31, 2024. The Trust's annual 2024 financial statements and Management's Discussion & Analysis ("MD&A") have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated.

CNW Group 2 months ago

DHTRF
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, at 8:00 a.m. ET. The Trust will report its financial results on Monday, March 3, 2025, after market close.

CNW Group 3 months ago

DHTRF
DRI Healthcare Trust Declares Special Unit Distribution

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that in accordance with the requirement for the Trust to distribute all of its taxable income for the year, its Board of Trustees has declared a special unit distribution of US$0.0237 per unit. The special unit distribution will be made payable to unitholders of record at the close of business on December 31, 2024. This special unit

CNW Group 4 months ago

DHTRF
DRI Healthcare Trust Reports Third Quarter 2024 Results

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the quarter ended September 30, 2024. The Trust's third quarter 2024 financial statements and Management's Discussion & Analysis ("MD&A") have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated.

CNW Group 6 months ago

DHTRF
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to US$179 million, comprised of a US$100 million upfront payment, up to US$57 million in a sales-based milestone payment and a one-time US$22 million optional payment. A

CNW Group 6 months ago

DHTRF
DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has entered into an amendment agreement to the existing amended and restated credit agreement (the "Agreement") with a syndicate of banks providing up to US$631.6 million of debt capacity. As part of the amendment, the interest rate on drawings was reduced by 0.25% based on the Trust's leverage ratio. The facilities are secured by all of the a

CNW Group 6 months ago

DHTRF
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its third quarter 2024 financial results on Thursday, November 7, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Wednesday, November 6, 2024, after market close.

CNW Group 6 months ago

DHTRF
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced that a wholly owned subsidiary of the Trust has acquired a portion of Editas Medicine, Inc.'s ("Editas") payment rights under a non-exclusive license to Vertex Pharmaceuticals Incorporated ("Vertex") of Editas Medicine's Cas9 gene-editing technology for CASGEVY® (exagamglogene autotemcel) for an upfront purchase price of US$57 million.

CNW Group 7 months ago

DHTRF
DRI Healthcare Trust Reports Second Quarter 2024 Results

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or the "Trust") today announced its financial results for the quarter ended June 30, 2024. The Trust's second quarter 2024 financial statements and Management's Discussion & Analysis ("MD&A") have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated.

CNW Group 9 months ago

DHTRF
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") and DRI Capital Inc. ("DRI Healthcare"), the manager of the Trust, today announced changes to their respective senior executive teams.

CNW Group 9 months ago

DHTRF
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its second quarter 2024 financial results on Wednesday, August 7, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Tuesday, August 6, 2024, after market close.

CNW Group 10 months ago

DHTRF
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS Therapeutics Inc. ("HLS") for an aggregate purchase price of up to US$45.75 million, comprised of a US$13.25 million upfront payment and up to US$32.5 million in performance-based outbound milestone payments.

CNW Group 10 months ago

DHTRF

Performance Overview

Return	DHT-UN.TO	S&P/TSX Composite index (^GSPTSE)
YTD	+8.02%	+3.70%
1-Year	-15.51%	+14.45%
3-Year	+108.71%	+29.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

DRI Healthcare Trust (DHT-UN.TO)

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

DRI Healthcare Trust Declares Special Unit Distribution

DRI Healthcare Trust Reports Third Quarter 2024 Results

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals

DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024

DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

DRI Healthcare Trust Reports Second Quarter 2024 Results

DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024

DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

Performance Overview